Connect your AI

Eikon Therapeutics, Inc. EIKN Depreciation

Depreciation at other companies

SolarEdge TechnologiesSEDG

$7.63M-49.0%

TransDigm GroupTDG

$44M+7.3%

Bloom EnergyBE

$13.28M+10.8%

Target HospitalityTH

$15.58M+13.9%

Comfort Systems USAFIX

$18.57M+32.5%

Illinois Tool WorksITW

$81M+9.5%

Other financials

Income statement

Operating income-$87.3M-22.3%

Net income-$83.0M-21.6%

EPS (diluted)-$2.46+90.9%

Balance sheet

Cash & equivalents$161.2M-21.2%

Total debt$254.8M—

Total equity$550.7M+186%

Total assets$850.8M—

Cash flow

Operating cash flow-$89.8M-64.7%

CapEx$262.0K-98.8%

Free cash flow-$90.1M-17.1%

Valuation

Market cap$521.35M—

Where this comes from

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eikon Therapeutics, Inc. 's depreciation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Eikon Therapeutics, Inc. 's depreciation?: Eikon Therapeutics, Inc. (EIKN) reported depreciation of $5.21M in Q1 2026.